China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)
北京紫竹医药经营有限公司
Why it is here
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — cartel (monopoly agreement) (北京市市场监管局北京市市场监管局 · 市场监管总局发布北京紫竹医药经营有限公司达成并实施垄断协议案行政处罚决定书), from 29 May 2023.
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Cartel (monopoly agreement).
Details
- Company
- 北京紫竹医药经营有限公司
- Authority
- State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
- Decision
- Cartel (monopoly agreement)
- Grounds and details, as published
- 北京市市场监管局北京市市场监管局 · 市场监管总局发布北京紫竹医药经营有限公司达成并实施垄断协议案行政处罚决定书
- From
- 29 May 2023
- Until
- —
- Status
- End date not published
- Source
- https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_c1e2b2afb9774086834cff4a5d052149.html
- Licence
- Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)
SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)